Mastering Risk Management Plans (DRMPs) in Clinical Drug Development: Comprehensive Overview of Requirements in China

In the rapidly evolving landscape of clinical drug development, understanding and mastering Developmental Risk Management Plans (DRMPs) is essential, especially for navigating regulatory requirements in China.

This session offers a comprehensive overview of Risk Management Plans (RMPs) and Developmental RMPs, which are crucial for identifying, characterizing, and mitigating the risks associated with medicinal products. Join us to learn about the unique DRMP requirements in China, along with practical insights into designing effective risk management strategies for medicinal products in clinical development.

Led by industry expert Vjera Bilušić Vundać, PhD Pharm, Senior Director of Medical Writing, this session dives deep into the essentials of DRMPs, from foundational definitions to specific requirements for the Chinese regulatory landscape. Whether you’re preparing for a clinical trial or looking to ensure compliance with Chinese DRMP regulations, this webinar provides actionable guidance to enhance your risk management approach.

Key Takeaways Include:

• Comprehensive understanding of RMPs and DRMPs for medicinal products
• Regulatory requirements for RMPs for marketed products and DRMPs in clinical development
• In-depth look at DRMP guidelines specific to China
• Best practices for designing and implementing DRMPs within the Chinese regulatory framework